Award Program Details
The Gund-Harrington Scholar Award supports innovative research efforts that could prevent, treat or cure blindness.
The Gund-Harrington Scholar Award is part of the Gund-Harington Initiative for Fighting Blindness.
Description of Funding
The awards are provided as milestone-driven payments totaling up to $900,000 over a three year timeframe. Up to 10 percent of the award may be requested as an upfront payment at the start of the award. Subsequent award payments will be made based on progress. Applications and award budgets should be built around key milestones. (Milestones are key points in a project which represent reliable, quantifiable indicators/deliverables of the project’s progress, and are used to make decisions on further progress.) If an award is made, Harrington Discovery Institute’s Innovation Support Center will work with recipients to help refine and manage project milestones.
The project must be structured to deliver a lead product with strong potential for clinical and commercial application.
Areas of interest include, but are not limited to:
- Treatment strategies that are not gene specific, but might be broadly applicable across many patients
- Therapies that may be effective in later stages of disease
- Gene modifying or gene therapy strategies
- Therapies that address juvenile macular degeneration
- Regenerative medicine therapies that focus on stem cells differentiated into photoreceptor cells
- Novel targets to address unmet need
Gund-Harrington Scholar Award projects should have the following characteristics:
- Innovative science potentially leading to treatment or prevention of inherited retinal degenerative diseases
- The potential to be developed into a commercial product
- Development of a small molecule or biologic
Diagnostics are only acceptable if linked to a therapeutic product.